Albertinen-Krankenhaus

Hamburg 22457

0 studies enrolling now · 6 studies all time

What they study most

Breast Cancer, HER2-Positive Primary Breast Cancer, Heart Failure, Heart Failure NYHA Class III and Ambulatory IV, Ischemic Stroke, Left Ventricular Dysfunction, Residual Invasive Breast Cancer, Systemic Embolism, Tricuspid Valve Insufficiency

Studies at this site

• PALbociclib CoLlaborative Adjuvant Study — Running, not enrolling
• A Study of Trastuzumab Deruxtecan (T-DXd) Versus Trastuzumab Emtansine (T-DM1) in High-risk HER2-positive Participants With Residual Invasive Breast Cancer Following Neoadjuvant Therapy (DESTINY-Breast05) — Running, not enrolling
• Left Atrial Appendage Exclusion for Prophylactic Stroke Reduction Trial — Running, not enrolling
• TRILUMINATE Study With Abbott Transcatheter Clip Repair System in Patients With Moderate or Greater TR — Completed
• Clinical Trial of the SonRtip Lead and Automatic AV-VV Optimization Algorithm in the PARADYM RF SonR CRT-D — Status unconfirmed
• INcrease Of VAgal TonE in CHF — Stopped early